Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2011 3
2012 8
2013 12
2014 22
2015 40
2016 105
2017 167
2018 209
2019 342
2020 343
2021 40
Text availability
Article attribute
Article type
Publication date

Search Results

1,134 results
Results by year
Filters applied: . Clear all
Page 1
Polypharmacy: Evaluating Risks and Deprescribing.
Halli-Tierney AD, Scarbrough C, Carroll D. Halli-Tierney AD, et al. Am Fam Physician. 2019 Jul 1;100(1):32-38. Am Fam Physician. 2019. PMID: 31259501 Free article. Review.
Physicians should view deprescribing as a therapeutic intervention similar to initiating clinically appropriate therapy. ...Point-of-care tools can aid physicians in deprescribing and help patients understand the need to decrease medication burden to reduce the risk …
Physicians should view deprescribing as a therapeutic intervention similar to initiating clinically appropriate therapy. ...Point-of- …
Deprescribing in older people.
Page AT, Potter K, Clifford R, Etherton-Beer C. Page AT, et al. Maturitas. 2016 Sep;91:115-34. doi: 10.1016/j.maturitas.2016.06.006. Epub 2016 Jun 18. Maturitas. 2016. PMID: 27451330 Review.
Most evidence for deprescribing relates to the withdrawal of specific medications, and evidence supports attempts to deprescribe potentially inappropriate medicines (such as long-term benzodiazepines). ...More work is needed to identify the sub-groups of older peopl …
Most evidence for deprescribing relates to the withdrawal of specific medications, and evidence supports attempts to deprescribe
Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, Goodlin SJ, Maurer MS, Alexander KP, Rich MW, Tjia J; Geriatric Cardiology Section Leadership Council, American College of Cardiology. Krishnaswami A, et al. J Am Coll Cardiol. 2019 May 28;73(20):2584-2595. doi: 10.1016/j.jacc.2019.03.467. J Am Coll Cardiol. 2019. PMID: 31118153 Free PMC article. Review.
Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medications with goals of care when life expectancy is reduced. Using a framework to deprescribe, this review addresses the rationale, evidenc …
Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medicatio …
Rational deprescribing in the elderly.
Williams S, Miller G, Khoury R, Grossberg GT. Williams S, et al. Ann Clin Psychiatry. 2019 May;31(2):144-152. Ann Clin Psychiatry. 2019. PMID: 31046036 Review.
Despite this, elderly patients are currently being prescribed a median of 7 medications, which often causes more harm than benefit, and emphasizes the importance of deprescribing. METHODS: Five classes of potentially inappropriate medications for the elderly population, es …
Despite this, elderly patients are currently being prescribed a median of 7 medications, which often causes more harm than benefit, and emph …
The Role of Patient Preferences in Deprescribing.
Holmes HM, Todd A. Holmes HM, et al. Clin Geriatr Med. 2017 May;33(2):165-175. doi: 10.1016/j.cger.2017.01.004. Epub 2017 Feb 23. Clin Geriatr Med. 2017. PMID: 28364989 Review.
Qualitative studies suggest that patients are interested in reducing medications, may need education about their medications to facilitate deprescribing, and highly value communication with their providers around deprescribing. This article focuses on patient prefer …
Qualitative studies suggest that patients are interested in reducing medications, may need education about their medications to facilitate …
Deprescribing medications in older people: a narrative review.
Salahudeen MS. Salahudeen MS. Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495. Drugs Today (Barc). 2018. PMID: 30209443 Review.
The purpose of deprescribing is to reduce inappropriate polypharmacy, medication burden and harm, and to improve patient health-related outcomes. ...Deprescribing should be considered after careful assessment of the patient's overall health, therapeutic goals, medic …
The purpose of deprescribing is to reduce inappropriate polypharmacy, medication burden and harm, and to improve patient health-relat …
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
Reeve E, Thompson W, Farrell B. Reeve E, et al. Eur J Intern Med. 2017 Mar;38:3-11. doi: 10.1016/j.ejim.2016.12.021. Epub 2017 Jan 5. Eur J Intern Med. 2017. PMID: 28063660 Review.
The aim of this narrative review is to provide an overview of "deprescribing"; firstly discussing the potential benefits and harms followed by the barriers to and enablers of deprescribing. ...Taking action on deprescribing can be facilitated by knowledge of …
The aim of this narrative review is to provide an overview of "deprescribing"; firstly discussing the potential benefits and harms fo …
Problems Associated with Deprescribing of Proton Pump Inhibitors.
Helgadottir H, Bjornsson ES. Helgadottir H, et al. Int J Mol Sci. 2019 Nov 2;20(21):5469. doi: 10.3390/ijms20215469. Int J Mol Sci. 2019. PMID: 31684070 Free PMC article. Review.
It is well known that a substantial number of patients on long-term PPI therapy can discontinue PPIs without recurrence of symptoms in deprescribing trials. What is unknown is how sustainable deprescribing should be undertaken in practice and how effective it is in …
It is well known that a substantial number of patients on long-term PPI therapy can discontinue PPIs without recurrence of symptoms in de
Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Blanco JR, Morillo R, Abril V, Escobar I, Bernal E, Folguera C, Brañas F, Gimeno M, Ibarra O, Iribarren JA, Lázaro A, Mariño A, Martín MT, Martinez E, Ortega L, Olalla J, Robustillo A, Sanchez-Conde M, Rodriguez MA, de la Torre J, Sanchez-Rubio J, Tuset M; Gesida and SEFH. Blanco JR, et al. Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21. Eur J Clin Pharmacol. 2020. PMID: 31865412 Review.
This supposes a greater risk of drug interactions, of hospitalization, falls, and death. In the last years, deprescribing has gained attention as a means to rationalize medication use. ...Because polypharmacy in HIV-infected patients show that a considerable percentage of …
This supposes a greater risk of drug interactions, of hospitalization, falls, and death. In the last years, deprescribing has gained …
Polypharmacy, the Elderly, and Deprescribing.
Jetha S. Jetha S. Consult Pharm. 2015 Sep;30(9):527-32. doi: 10.4140/TCP.n.2015.527. Consult Pharm. 2015. PMID: 26350893
Empowering clinicians with evidence-based guidance to safely and effectively discontinue PIMs by "deprescribing" is the subject of current research. Pharmacists can play an important role as part of the circle of care for the elderly. ...
Empowering clinicians with evidence-based guidance to safely and effectively discontinue PIMs by "deprescribing" is the subject of cu …
1,134 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page